Lowey Dannenberg, P.C. is Investigating Astrana Health, Inc. (NASDAQ: ASTH) for Potential Violations of the Federal Securities Laws

NEW YORK, Sept. 22, 2026 (GLOBE NEWSWIRE) -- Lowey Dannenberg P.C., a preeminent law firm in obtaining redress for consumers and investors, is investigating Astrana Health, Inc. (NASDAQ: ASTH) (“Astrana” or the “Company”) for potential violations of the federal securities laws.

On September 17, 2026, Glass House Research published a report alleging that Astrana’s growth relies on aggressive acquisitions and subjective management estimates rather than organic expansion. The report also raised concerns about a $545 million related-party loan and the Company’s exposure to anticipated 2027 Medicare regulatory changes. The investigation concerns whether Astrana and its officers and/or directors made false and/or misleading statements and/or failed to disclose these risks, and whether the Company had a reasonable basis for its positive statements about its business, financial condition, and prospects.